Furthermore, higher frequencies of NKG2C+ NK cells in HCMV-seropositive individuals with MS have been associated with lower disability scores and a decreased risk of disability progression, suggesting a potential protective effect mediated through enhanced immunoregulatory functions (137). Here, KLRC2 is linked to myeloid sarcoma.